Trends in U.S and global patient enrollment from 2014 to 2022 in lung cancer clinical trials supporting marketing applications: An FDA analysis

被引：0
|
作者：
Akinboro, Oladimeji
Kumar, Vaibhav
Drezner, Nicole Lauren
Larkins, Erin A.
Pazdur, Richard
Kluetz, Paul
Singh, Harpreet
机构：
[1] US FDA, Ctr Drug Evaluat & Res, Off Oncol Dis, Off New Drugs, Silver Spring, MD USA
[2] US FDA, Oncol Ctr Excellence, Silver Spring, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1576
引用
收藏
页数：1
相关论文
共 22 条
  • [1] US FDA analysis of enrollment of Asian patients from India in cancer clinical trials leading to approval from 2010 to 2022.
    Srivastava, Geetika
    Leong, Ruby
    Nair, Abhilasha
    Kanapuru, Bindu
    Rizvi, Fatima
    Yang, Felice
    Lee, Jennifer J.
    Wedam, Suparna B.
    Dilawari, Asma Ali
    Fan, Chaohong
    Lee, Sso
    Andrada, Frances
    Lee, Clara
    Rivera, Donna
    Lemery, Steven
    Gao, Jennifer
    Kim, Tamy
    Pazdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Global research trends between gut microbiota and lung cancer from 2011 to 2022: A bibliometric and visualization analysis
    Chen, Haitao
    Lai, Yuebiao
    Ye, Chenxiao
    Wu, Changhong
    Zhang, Jiali
    Zhang, Zewei
    Yao, Qinghua
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Differences in clinical trial patient attributes and outcomes according to trial enrollment setting: analyses from 10 CALGB lung cancer trials
    Lamont, E. B.
    Archer, L. E.
    Lan, L.
    Vokes, E. E.
    McNeil, B. J.
    Keating, N. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] FDA overview of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January 2008 and December 2017
    Fiero, Mallorie
    Roydhouse, Jessica
    Vallejo, Jonathon
    King-Kallimanis, Bellinda
    Kluetz, Paul
    Sridhara, Rajeshwari
    QUALITY OF LIFE RESEARCH, 2019, 28 : S57 - S58
  • [5] Global Trends in Lung Cancer Survival by Morphology: Analysis from 61 Countries During 2000-2014 (CONCORD-3)
    Zhu, H.
    Di Carlo, V.
    Khan, F.
    Allemani, C.
    Coleman, M. P.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S420 - S420
  • [6] A Prospective Analysis of the Influence of Older Age on Physician and Patient Decision-Making When Considering Enrollment in Breast Cancer Clinical Trials (SWOG S0316)
    Javid, Sara H.
    Unger, Joseph M.
    Gralow, Julie R.
    Moinpour, Carol M.
    Wozniak, Antoinette J.
    Goodwin, J. Wendall
    Lara, Primo N., Jr.
    Williams, Pamela A.
    Hutchins, Laura F.
    Gotay, Carolyn C.
    Albain, Kathy S.
    ONCOLOGIST, 2012, 17 (09): : 1180 - 1190
  • [7] Global research trends of tumor microenvironment in non-small cell lung cancer with epidermal growth factor receptor mutation: a bibliometric analysis from 2014 to 2023
    Chang, Xiaoyan
    Wang, Chenghao
    Wang, Fei
    Zhang, Linyou
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [8] Multi-level intervention to increase minority cancer patient enrollment to clinical treatment trials- Study design considerations and baseline characteristics from the ACTWONDER2S Study
    Rollison, Dana E.
    Amorrortu, Rossybelle P.
    Fuzzell, Lindsay N.
    Garcia, Melany A.
    Tapia-Kwan, Elliott S.
    Zhao, Yayi
    Eschrich, Steven A.
    Gore, Bob R.
    Mittman, Brian S.
    Stanley, Nathanael B.
    Vadaparampil, Susan T.
    CANCER RESEARCH, 2024, 84 (06)
  • [9] A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients
    Stinchcombe, Thomas E.
    Fan, Wen
    Schild, Steven E.
    Vokes, Everett E.
    Bogart, Jeff
    Le, Quynh-Thu
    Thomas, Charles R., Jr.
    Edelman, Martin J.
    Horn, Leora
    Komaki, Ritsuko
    Cohen, Harvey J.
    Ganti, Apar Kishor
    Pang, Herbert
    Wang, Xiaofei
    CANCER, 2019, 125 (03) : 382 - 390
  • [10] Determinants of Patient's Global Assessment of Disease Activity and Physician's Global Assessment of Disease Activity in patients with rheumatoid arthritis: A post hoc analysis of overall and Japanese results from phase 3 clinical trials
    Kaneko, Yuko
    Takeuchi, Tsutomu
    Cai, Zhihong
    Sato, Masayo
    Awakura, Kenta
    Gaich, Carol
    Zhu, Baojin
    Guo, Jiaying
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2018, 28 (06) : 960 - 967
123